Month: May 2021

NhTherAguix: NH TherAguix and the CHU Grenoble-Alpes announce the publication of the results of the First-In-Human phase 1 clinical trial on the combination of AGuIX with radiotherapy

GRENOBLE, FRANCE / ACCESSWIRE / May 31, 2021 / NH TherAguix ("NHT"), a clinical stage company developing innovative nanomedicines for...

CureVac’s First-Generation COVID-19 Vaccine Candidate, CVnCoV, Continues Toward Phase 2b/3 Efficacy Readout in Variant-rich Environment Following DSMB Recommendation

Study continues to progress according to protocol following first interim analysis at 59 eligible COVID-19 cases Sequencing data to be...

error: Content is protected !!